SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-21-001609
Filing Date
2021-02-12
Accepted
2021-02-12 16:16:22
Documents
55
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTELRY REPORT cvm_10q.htm   iXBRL 10-Q 610160
2 CERTIFICATIONS cvm_ex31.htm EX-31 26030
3 IN CONNECTION WITH THE QUARTERLY REPORT OF CEL-SCI CORPORATION (THE COMPANY ) ON cvm_ex32.htm EX-32 4050
  Complete submission text file 0001654954-21-001609.txt   3677313

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cvm-20201231.xsd EX-101.SCH 44202
5 XBRL CALCULATION FILE cvm-20201231_cal.xml EX-101.CAL 43476
6 XBRL DEFINITION FILE cvm-20201231_def.xml EX-101.DEF 103967
7 XBRL LABEL FILE cvm-20201231_lab.xml EX-101.LAB 277867
8 XBRL PRESENTATION FILE cvm-20201231_pre.xml EX-101.PRE 222662
9 EXTRACTED XBRL INSTANCE DOCUMENT cvm_10q_htm.xml XML 570564
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

IRS No.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-11889 | Film No.: 21627607
SIC: 2836 Biological Products, (No Diagnostic Substances)